Physical TherapyNCT07505368
SWT VERSUS EMFT IN KOA
A study testing Shock Wave Therapy, Electromagnetic Field Therapy and Conservative therapy in people with Physical Therapy, run by Suez Canal University at 1 site in Egypt.
Trial summary
The purpose of this study was to compare the effect of extracorporeal shock wave therapy and pulsed electromagnetic field in reducing pain, improving function, and increasing ROM in knee osteoarthritis patients. Read more about this study
- Who is it for?
- Ages 40 to 60 years
- Conditions the study is for
- Physical Therapy
- What is being tested?
- Shock Wave Therapy, Electromagnetic Field Therapy and Conservative therapy
- Type of treatment
- Surgery or procedure
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 60 participants
- Where
- 1 siteEgypt
- Study dates
- 1 Jan 2025to 1 Mar 2026
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 40 to 60 years
- All sexes
- No healthy volunteers
- Adult
Who may be able to join
- Sixty patients must have a confirmed diagnosis of knee osteoarthritis, specifically those with mild to moderate osteoarthritis.
- Participants must have experienced knee pain lasting more than 3 months.
- Their ages will be ranged from 40 to 60 years.
- Their body mass index within the range of 22.7 to 28.5 kg/m² kg/m².
- Both male and female patients are eligible for the study.
- At least two positive provocative tests, such as joint line tenderness and crepitus, which are commonly associated with knee osteoarthritis.
Who cannot join
- Inflammatory arthritis (e.g., rheumatoid arthritis) or other forms of arthritis that are not osteoarthritis.
- Undergone knee replacement surgery or any significant knee surgery within the past year.
- Severe cardiovascular, respiratory, renal, or hepatic diseases that could interfere with study participation or outcomes.
- Received intra-articular corticosteroid injections in the affected knee within the last 3 months.
- Pregnant or breastfeeding due to the unknown effects of study treatments on fetal and infant development.
- Neurological conditions affecting the lower limbs (e.g., stroke, neuropathy). body mass index greater than 30 kg/m², as severe obesity may influence treatment outcomes and complicate assessment.
- Cognitive impairments or psychiatric conditions that may affect their ability to participate.
Trial locations and contacts
1 site in 1 country.
Egypt1 site
The Outpatient Clinics, Faculty of Physical Therapy Suez Canal University
Ismailia
About this study
Official title: SHOCK WAVE THERAPY VERSUS ELECTROMAGNETIC FIELD THERAPY IN KNEE OSTEOARTHRITIS
The purpose of this study was to compare the effect of extracorporeal shock wave therapy and pulsed electromagnetic field in reducing pain, improving function, and increasing ROM in knee osteoarthritis patients.
Read the detailed description
Knee osteoarthritis is a prevalent and debilitating condition that affects millions of people worldwide. It is particularly common in older adults and is a major cause of disability and reduced quality of life. The disease is characterized by the progressive degradation of articular cartilage, leading to pain, stiffness, and impaired function. The prevalence of knee osteoarthritis has been reported to range between 22% to 39% globally, and in specific regions like India, it is approximately 28.7%.
Extracorporeal shock wave therapy has emerged as a promising non-invasive treatment for knee osteoarthritis. The advantages of extracorporeal shock wave therapy include its ability to alleviate pain and improve joint function. Studies have demonstrated that extracorporeal shock wave therapy can significantly reduce pain scores and enhance physical function in patients with knee osteoarthritis, making it a viable treatment option. Additionally, extracorporeal shock wave therapy has been shown to positively affect cartilage regeneration and reduce inflammation markers like matrix metalloproteinase-3, which is involved in cartilage degradation.
However, the disadvantages of extracorporeal shock wave therapy include the potential for adverse effects on articular cartilage, particularly at higher intensities, which may result in the worsening of cartilage conditions in some cases. Furthermore, while extracorporeal shock wave therapy is generally well-tolerated, its efficacy may vary depending on the energy levels used, with moderate intensity showing the best outcomes.
- Conditions
- Physical Therapy
- Being tested
- Shock Wave Therapy, Electromagnetic Field Therapy, Conservative therapy
- Keywords
- Shock Wave Therapy, Electromagnetic Field Therapy, Knee Osteoarthritis
- Medical subject headings
- Osteoarthritis, Knee
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Shock Wave TherapyProcedure or surgery
Electrotherapy application
Electromagnetic Field TherapyProcedure or surgery
Electrotherapy application
Conservative therapyProcedure or surgery
Hot pack, stretching exercises and strengthening exercises
| Study group | Role | What they receive |
|---|---|---|
| Group A | Experimental | Experimental group 1. Receives: Procedure: Shock Wave Therapy; Procedure: Conservative therapy |
| Group B | Experimental | Experimental group 2. Receives: Procedure: Electromagnetic Field Therapy; Procedure: Conservative therapy |
| Group C | Experimental | Experimental group 3. Receives: Procedure: Conservative therapy |
What is being measured
The primary outcome is the main question the study is designed to answer.
Change in physical function.
Measurement of physical function using the Western Ontario and McMaster Universities Osteoarthritis Index.
Measured: Pretreatment measurement and posttreatment (4 weeks) measurement.
Change in pain intensity
Measurement of pain intensity using the visual analogue scale.
Measured: Pretreatment measurement and posttreatment (4 weeks) measurement.
Change in range of motion.
Measurement of range of motion using the digital goniometer.
Measured: Pretreatment measurement and posttreatment (4 weeks) measurement.
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted1 Apr 2026
- Study start1 Jan 2025
- Primary completion31 Dec 2025
- Study completion1 Mar 2026
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Physical TherapyStudies of the same condition, open and under way.
- More trials run by Suez Canal UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- Randomized controlled trial
- Masking
- Single blind
- Who is masked
- Participant
- Enrolment
- 60 participants (actual)
Sponsor and investigators
- Lead sponsor
- Suez Canal University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Maha mussa, Suez Canal University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07505368
- Sponsor's protocol ID
- SUEZPT2025
- Status last verified
- Mar 2026
- First submitted
- 17 Nov 2025
- Last updated
- 1 Apr 2026
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 1 Apr 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- SHOCK WAVE THERAPY VERSUS ELECTROMAGNETIC FIELD THERAPY IN KNEE OSTEOARTHRITIS
- ClinicalTrials.gov ID
- NCT07505368
- Acronym / sponsor ID
- SUEZPT2025
- Conditions
- Physical Therapy
- Keywords
- Shock Wave Therapy, Electromagnetic Field Therapy, Knee Osteoarthritis
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 60 participants (actual)
- Lead sponsor
- Suez Canal UniversityUniversity, hospital or other
- Study start
- 1 Jan 2025 (actual)
- Primary completion
- 31 Dec 2025 (actual)
- Study completion
- 1 Mar 2026 (actual)
- First posted
- 1 Apr 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The purpose of this study was to compare the effect of extracorporeal shock wave therapy and pulsed electromagnetic field in reducing pain, improving function, and increasing ROM in knee osteoarthritis patients.
Detailed description
Knee osteoarthritis is a prevalent and debilitating condition that affects millions of people worldwide. It is particularly common in older adults and is a major cause of disability and reduced quality of life. The disease is characterized by the progressive degradation of articular cartilage, leading to pain, stiffness, and impaired function. The prevalence of knee osteoarthritis has been reported to range between 22% to 39% globally, and in specific regions like India, it is approximately 28.7%.
Extracorporeal shock wave therapy has emerged as a promising non-invasive treatment for knee osteoarthritis. The advantages of extracorporeal shock wave therapy include its ability to alleviate pain and improve joint function. Studies have demonstrated that extracorporeal shock wave therapy can significantly reduce pain scores and enhance physical function in patients with knee osteoarthritis, making it a viable treatment option. Additionally, extracorporeal shock wave therapy has been shown to positively affect cartilage regeneration and reduce inflammation markers like matrix metalloproteinase-3, which is involved in cartilage degradation.
However, the disadvantages of extracorporeal shock wave therapy include the potential for adverse effects on articular cartilage, particularly at higher intensities, which may result in the worsening of cartilage conditions in some cases. Furthermore, while extracorporeal shock wave therapy is generally well-tolerated, its efficacy may vary depending on the energy levels used, with moderate intensity showing the best outcomes.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (participant)
- Number of arms
- 3
- Model description
- Randomized controlled trial
| Arm | Type | Receives |
|---|---|---|
| Group A | Experimental | Procedure: Shock Wave Therapy, Procedure: Conservative therapyExperimental group 1. |
| Group B | Experimental | Procedure: Electromagnetic Field Therapy, Procedure: Conservative therapyExperimental group 2. |
| Group C | Experimental | Procedure: Conservative therapyExperimental group 3. |
Who may qualify
- Ages
- 40 to 60 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult
Key inclusion criteria (6 listed)
- Sixty patients must have a confirmed diagnosis of knee osteoarthritis, specifically those with mild to moderate osteoarthritis.
- Participants must have experienced knee pain lasting more than 3 months.
- Their ages will be ranged from 40 to 60 years.
- Their body mass index within the range of 22.7 to 28.5 kg/m² kg/m².
- Both male and female patients are eligible for the study.
Key exclusion criteria (7 listed)
- Inflammatory arthritis (e.g., rheumatoid arthritis) or other forms of arthritis that are not osteoarthritis.
- Undergone knee replacement surgery or any significant knee surgery within the past year.
- Severe cardiovascular, respiratory, renal, or hepatic diseases that could interfere with study participation or outcomes.
- Received intra-articular corticosteroid injections in the affected knee within the last 3 months.
- Pregnant or breastfeeding due to the unknown effects of study treatments on fetal and infant development.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Shock Wave TherapyElectrotherapy application | Procedure or surgery | Group A |
| Electromagnetic Field TherapyElectrotherapy application | Procedure or surgery | Group B |
| Conservative therapyHot pack, stretching exercises and strengthening exercises | Procedure or surgery | Group A, Group B, Group C |
Primary outcome
Change in physical function.
Time frame: Pretreatment measurement and posttreatment (4 weeks) measurement.
Measurement of physical function using the Western Ontario and McMaster Universities Osteoarthritis Index.
Change in pain intensity
Time frame: Pretreatment measurement and posttreatment (4 weeks) measurement.
Measurement of pain intensity using the visual analogue scale.
Change in range of motion.
Time frame: Pretreatment measurement and posttreatment (4 weeks) measurement.
Measurement of range of motion using the digital goniometer.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 1 Apr 2026.
- Individual participant dataSharing planned: No
Related trials for Physical Therapy
Recruiting
The Effectiveness of Structured Swallowing Exercise Therapy in Patients With Nasopharyngeal Carcinoma: An Assessment of Swallowing Function and Quality of Life
Nasopharyngeal Carcinoma (NPC)
Recruiting
Impact of a Structured Wellness Behavioral Intervention on Quality of Life in NMOSD
Neuromyelitis Optica Spectrum Disorder (NMOSD)
Recruiting
Physiotherapy or Fasciotomy as Treatment for Chronic Exertional Compartment Syndrome in the Lower Leg?
Compartment Syndrome Nontraumatic Lower Leg
Not yet recruiting
Boosting Exercise Adherence in Knee Osteoarthritis
Osteoarthritis, Knee
RecruitingObservational study
Respiratory Physiotherapy and Inflammatory Biomarkers in Critically Ill Patients With Pneumonia
Pneumonia, Critical Illness
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Shock Wave Therapy, Electromagnetic Field Therapy and Conservative therapy in people with Physical Therapy, run by Suez Canal University at 1 site in Egypt.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 6 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 1 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Change in physical function. (time frame: Pretreatment measurement and posttreatment (4 weeks) measurement.). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Apr 2026.